PTK2 and neoplasm: The combined use of FAK inhibitors with liposomal doxorubicin (119) and the ozone-liposome enhanced radiotherapy technology (120) both demonstrate that tumor antigens produced by ICD can establish a self-reinforcing anti-tumor immune cycle.